Hyperlipidemia is a very common multifactorial disease, the onset and progression of which are determined by genetic risk as well as by environmental factors (Hegele 2001; Cullen et al. 1997).
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless ...
To investigate whether altering energy intake as red meat protein or carbohydrate modifies chylomicron homeostasis and postprandial lipaemia. Participants consumed an isocaloric weight maintenance ...